Related references
Note: Only part of the references are listed.Leukocyte diversity in resolving and nonresolving mechanisms of cardiac remodeling
Bochra Tourki et al.
FASEB JOURNAL (2017)
Aging dysregulates D- and E-series resolvins to modulate cardiosplenic and cardiorenal network following myocardial infarction
Ganesh V. Halade et al.
AGING-US (2016)
Activation of autophagy in macrophages by pro-resolving lipid mediators
Patricia Prieto et al.
AUTOPHAGY (2015)
Innate Immunity and the Failing Heart The Cytokine Hypothesis Revisited
Douglas L. Mann
CIRCULATION RESEARCH (2015)
The kidney in heart failure: an update
Kevin Damman et al.
EUROPEAN HEART JOURNAL (2015)
Predicting the influence of liposomal lipid composition on liposome size, zeta potential and liposome-induced dendritic cell maturation using a design of experiments approach
Peter C. Soema et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2015)
Lipoxin A4 Attenuates Constitutive and TGF-β1-Dependent Profibrotic Activity in Human Lung Myofibroblasts
Katy M. Roach et al.
JOURNAL OF IMMUNOLOGY (2015)
Resolvin D1 activates the inflammation resolving response at splenic and ventricular site following myocardial infarction leading to improved ventricular function
Vasundhara Kain et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2015)
Building a better infarct: Modulation of collagen cross-linking to increase infarct stiffness and reduce left ventricular dilation post-myocardial infarction
Andrew P. Voorhees et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2015)
Splenic Metabolic Activity Predicts Risk of Future Cardiovascular Events
Hamed Emami et al.
JACC-CARDIOVASCULAR IMAGING (2015)
Isolation of Murine Peritoneal Macrophages to Carry Out Gene Expression Analysis Upon Toll-like Receptors Stimulation
Antonio Layoun et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2015)
The role of the FPR2/ALX receptor in atherosclerosis development and plaque stability
Marcelo H. Petri et al.
CARDIOVASCULAR RESEARCH (2015)
Inflammation revisited: inflammation versus resolution of inflammation following myocardial infarction
Vasundhara Kain et al.
BASIC RESEARCH IN CARDIOLOGY (2014)
Impaired resolution of inflammation in human chronic heart failure
Marta Reina-Couto et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2014)
The inflammatory response in myocardial injury, repair, and remodelling
Nikolaos G. Frangogiannis
NATURE REVIEWS CARDIOLOGY (2014)
Efficacy and safety of 15(R/S)-methyl-lipoxin A4 in topical treatment of infantile eczema
S-H Wu et al.
BRITISH JOURNAL OF DERMATOLOGY (2013)
Matrix Metalloproteinase-28 Deletion Exacerbates Cardiac Dysfunction and Rupture After Myocardial Infarction in Mice by Inhibiting M2 Macrophage Activation
Yonggang Ma et al.
CIRCULATION RESEARCH (2013)
Resolution phase lipid mediators of inflammation: agonists of resolution
Charles N. Serhan et al.
CURRENT OPINION IN PHARMACOLOGY (2013)
Signal Relay by CC Chemokine Receptor 2 (CCR2) and Formylpeptide Receptor 2 (Fpr2) in the Recruitment of Monocyte-derived Dendritic Cells in Allergic Airway Inflammation
Keqiang Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Regulation of the Inflammatory Response in Cardiac Repair
Nikolaos G. Frangogiannis
CIRCULATION RESEARCH (2012)
Lyophilization of cholesterol-free PEGylated liposomes and its impact on drug loading by passive equilibration
Anumita Chaudhury et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2012)
Liposome based systems for systemic siRNA delivery: Stability in blood sets the requirements for optimal carrier design
Kevin Buyens et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Altering the immune response with lipid-based nanoparticles
Dalit Landesman-Milo et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Novel Lipid Mediators Promote Resolution of Acute Inflammation Impact of Aspirin and Statins
Matthew Spite et al.
CIRCULATION RESEARCH (2010)
FPR2/ALX receptor expression and internalization are critical for lipoxin A4 and annexin-derived peptide-stimulated phagocytosis
Paola Maderna et al.
FASEB JOURNAL (2010)
Activation of human monocytes by a formyl peptide receptor 2-derived pepducin
Ha Young Lee et al.
FEBS LETTERS (2010)
Strategies in the design of nanoparticles for therapeutic applications
Robby A. Petros et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Resolvin D1 binds human phagocytes with evidence for proresolving receptors
Sriram Krishnamoorthy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Identification of Splenic Reservoir Monocytes and Their Deployment to Inflammatory Sites
Filip K. Swirski et al.
SCIENCE (2009)
Inflammation and cardiovascular disease - Role of the interleukin-1 receptor antagonist
William F. Fearon et al.
CIRCULATION (2008)
IL-6 regulates neutrophil trafficking during acute inflammation via STAT3
Ceri A. Fielding et al.
JOURNAL OF IMMUNOLOGY (2008)
Neutrophil migration induced by IL-1β depends upon LTB4 released by macrophages and upon TNF-α and IL-1β released by mast cells
S. H. P. Oliveira et al.
INFLAMMATION (2008)
Cyclosporin H, Boc-MLF and Boc-FLFLF are antagonists that preferentially inhibit activity triggered through the formyl peptide receptor
Anna-Lena Stenfeldt et al.
INFLAMMATION (2007)
Bidirectional role of tumor necrosis factor-α in coronary microembolization -: Progressive contractile dysfunction versus delayed protection against infarction
Andreas Skyschally et al.
CIRCULATION RESEARCH (2007)
Augmentation of myocardial production of 15-epi-lipoxin-A4 by pioglitazone and atorvastatin in the rat
Yochai Birnbaum et al.
CIRCULATION (2006)
Aspirin has a gender-dependent impact on Antiinflammatory 15-epi-lipoxin A4 formation -: A randomized human trial
N Chiang et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Drug-associated renal dysfunction and injury
D Choudhury et al.
NATURE CLINICAL PRACTICE NEPHROLOGY (2006)
Resolution of inflammation: The beginning programs the end
CN Serhan et al.
NATURE IMMUNOLOGY (2005)
Encapsulation efficiency of water-soluble and insoluble drugs in liposomes prepared by the microencapsulation vesicle method
T Nii et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2005)
Lipoxins and aspirin-triggered 15-epi-lipoxins are the first lipid mediators of endogenous anti-inflammation and resolution
CN Serhan
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2005)
Cyclooxygenase-2 (COX-2) in acute myocardial infarction: cellular expression and use of selective COX-2 inhibitor
T Saito et al.
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2003)
Kidney Injury Molecule-1 (KIM-1): A novel biomarker for human renal proximal tubule injury
WK Han et al.
KIDNEY INTERNATIONAL (2002)
Left ventricular remodeling after myocardial infarction - Pathophysiology and therapy
MGS Sutton et al.
CIRCULATION (2000)
Share Paper
